QIAGEN N.V. filed a Form 6-K with the SEC on November 5, 2026, furnishing a press release that announced unaudited financial results for the third quarter ended September 30, 2026.

Key Highlights

  • Filing period: The report covers the quarterly period ended September 30, 2026.
  • Press release date: QIAGEN issued its Q3 2026 earnings press release on November 4, 2026, according to the filing.
  • Non-GAAP measures disclosed: The company reported the use of adjusted non-GAAP measures including gross profit, operating income, pre-tax income, net income, tax rate, and diluted earnings per share.
  • Free cash flow definition: The filing states free cash flow is calculated as net cash from operating activities less purchases of property, plant and equipment.
  • Constant currency reporting: The company disclosed that constant currency figures are calculated using average exchange rates from the prior year's respective period in place of current-period rates.
  • Signed by: The filing was signed by Roland Sackers, Chief Financial Officer, on November 5, 2026.

QIAGEN's Q3 2026 6-K: Non-GAAP Framework and Earnings Announcement

QIAGEN N.V. (NYSE:QGEN; Frankfurt, Prime Standard: QIA), headquartered in Venlo, The Netherlands, submitted a Form 6-K to the U.S. Securities and Exchange Commission furnishing a press release dated November 4, 2026, which announced unaudited financial results for the third quarter ended September 30, 2026. The press release is incorporated by reference as Exhibit 99.1. The underlying financial figures themselves appear in the attached press release rather than in the body of the 6-K form.

The filing describes at length how QIAGEN presents adjusted, non-GAAP financial results alongside its GAAP results. According to the filing, excluded items include "costs related to business integration, acquisition and restructuring related items, long-lived asset impairments, amortization of acquired intangible assets, non-cash interest expense charges as well as other special income and expense items." The company stated that management views these costs as "not indicative of the profitability or cash flows of our ongoing or future operations." The filing notes that adjusted results should be considered a supplement to, not a substitute for, GAAP results, and that reconciliations are included in the tables accompanying the press release.

The filing also explains QIAGEN's use of constant currency reporting, noting that because a significant portion of revenues and expenses is denominated in euros and other non-U.S. currencies, management believes constant currency comparisons are useful for assessing period-over-period growth. The company disclosed that it does not reconcile forward-looking non-GAAP measures to GAAP due to what it described as "high variability and difficulty in making accurate forecasts," but cautioned that "the actual amounts of these excluded items will have a significant impact on QIAGEN's GAAP results."

What Was Disclosed

QIAGEN filed a Form 6-K on November 5, 2026, furnishing its Q3 2026 earnings press release as an exhibit. The filing primarily described the company's non-GAAP measurement framework, constant currency methodology, and free cash flow definition, with the actual financial results contained in the attached press release.